IPO Price History
Closed
Molbio Diagnostics Ltd. logo

Molbio Diagnostics Ltd. IPO

Mainboard IPOListedMOLBIOBSE, NSE
Current Market Price (CMP)
₹1,239.10(+53.54%)
Sector: Hospital & Healthcare Services
Current Price (CMP)
₹1,239.10(+53.54%)

Live Market Quote

Listing Price & Gain
₹1,041.70(+29.08%)

Day 1 Exchange Open

IPO Issue Price
₹807

Band: ₹768 - ₹807

Total Subscription
70.26x

Overall Bid Demand

Total Issue Size
₹939.7 Cr

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
10 Aug 2026
IPO Bidding Closes
12 Aug 2026
Allotment & Refunds
13 Aug 2026
Exchange Listing Day
17 Aug 2026

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 70.26x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)186.39x
Non-Institutional Investors (NII / HNI)49.8x
Retail Individual Investors (RII)12.96x
Employees Reservation13.28x
Total Subscription70.26x
Updated as on 12-Aug-2026 19:00:00

Listing Day & Return Performance

Listing Day Gain+29.08%
₹807 (Issue) → ₹1,041.70 (List)
Per share profit: +₹234.70
Holding Return (Till Date)+53.54%
₹807 (Issue) → ₹1,239.10 (CMP)
Net gain per share: +₹432.10
Post-Listing Performance (Listing Day → Today):+18.95%

About Molbio Diagnostics Ltd. IPO

Molbio Diagnostics Ltd. is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 10 Aug 2026 and concluded on 12 Aug 2026, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹768 - ₹807. The aggregate issue size was approximately ₹939.7 crore. The company operates primarily within the Hospital & Healthcare Services sector.

During the bidding window, Molbio Diagnostics Ltd. witnessed heavy demand with an overall subscription of 70.26 times. Institutional investors (QIB) subscribed 186.39x, non-institutional high-net-worth investors (NII) subscribed 49.8x, and retail individual investors (RII) bid 12.96x their reserved quota, alongside employee participation of 13.28x.

The equity shares of Molbio Diagnostics Ltd. officially debuted on the stock exchanges on 17 Aug 2026 at an opening listing price of ₹1,041.70, delivering a listing day return of +29.08% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,239.10, representing an overall gain of +53.54% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Molbio Diagnostics Ltd. IPO?
The issue price of Molbio Diagnostics Ltd. IPO was fixed at ₹807 per equity share. The indicative bidding price band was ₹768 - ₹807.
What was the total issue size of Molbio Diagnostics Ltd. IPO?
The total issue size of Molbio Diagnostics Ltd. IPO was approximately ₹939.7 crore.
What were the open, close, and listing dates for Molbio Diagnostics Ltd. IPO?
Molbio Diagnostics Ltd. IPO opened on 10 Aug 2026, closed on 12 Aug 2026, listed on 17 Aug 2026.
How much was Molbio Diagnostics Ltd. IPO subscribed?
The IPO received an overall subscription of 70.26 times. Category-wise, QIBs subscribed 186.39x, NIIs subscribed 49.8x, and Retail investors subscribed 12.96x.
What was the listing price and listing gain of Molbio Diagnostics Ltd. IPO?
Molbio Diagnostics Ltd. IPO listed on the stock exchange at ₹1,041.70, delivering a listing gain of 29.08% compared to the IPO issue price of ₹807.
Is Molbio Diagnostics Ltd. IPO a Mainboard or SME IPO?
Molbio Diagnostics Ltd. IPO is a Mainboard IPO listed on the main exchange of BSE, NSE.
What is the current return of Molbio Diagnostics Ltd. IPO since its IPO?
At the latest market quote of ₹1,239.10, Molbio Diagnostics Ltd. IPO has generated an all-time return of +53.54% since its initial public offering.

Related Mainboard IPOs (2026)

AONESTEELS
A-One Steels India Ltd.
₹405+12.35%
ARMEE
ArMee Infotech Ltd.
₹100+275.00%
VARMORA
Varmora Granito Ltd.
₹148+4.73%
SONA
Sonaselection India Ltd.
₹99+3.34%